Welcome to the Earlitec Blog

EarliTec Diagnostics today announced its rebrand as EarliPoint Health, marking a bold new chapter in the company’s mission to transform autism care.

EarliTec Diagnostics, a leader in eye-tracking technology for early autism diagnosis and ongoing assessment, announced the appointment of Jamie Pagliaro as its

• Funding round led by Nexus NeuroTech Ventures and Venture Investors Health Fund• New investment will advance R&D efforts of first-in-kind autism

Artificial intelligence (AI) now performs feats that would have seemed far-fetched just a short few years ago. Users simply enter prompts and

EarliPoint Evaluation, the first-of-its-kind FDA-authorized device, is a gamechanger for early diagnosis of Autism spectrum disorder. Marcus Autism Center (marcus.org), a subsidiary

ATLANTA — New technology is helping families at Marcus Autism Center get answers faster. The center, part of Children’s Healthcare of Atlanta,

Two years ago, Good Morning America featured a segment with Dr. Jennifer Ashton discussing a promising new study that explored how eye-tracking

Data show that the clinically-validated, FDA-authorized EarliPointTM Evaluation for autism can provide objective, standardized, quantitative and cost-effective early assessment of autism, enabling greater access

The second generation of EarliPoint™ Evaluation uses a tablet to aid clinicians in diagnosing and assessing autism in children as young as